» Articles » PMID: 31781265

A Network Pharmacology Approach to Uncover the Molecular Mechanisms of Herbal Formula Kang-Bai-Ling for Treatment of Vitiligo

Overview
Date 2019 Nov 30
PMID 31781265
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Kang-bai-ling (KBL), a Chinese patent medicine, has been demonstrated as an effective therapy for vitiligo in China. However, the pharmacological mechanisms of KBL have not been completely elucidated.

Methods: In this study, the potential multicomponent, multitarget, and multipathway mechanism of KBL against vitiligo was clarified by using network pharmacology-based strategy. In brief, potential targets of KBL were collected based on TCMSP databases, followed by network establishment concerning the interactions of potential targets of KBL with well-known therapeutic targets of vitiligo by using protein-protein interaction (PPI) data. As a result, key nodes with higher level of seven topological parameters, including "degree centrality (DC)," "betweenness centrality (BC)," "closeness centrality (CC)," "eigenvector centrality (EC)," "network centrality (NC)," and "local average connectivity (LAC)" were identified as the main targets in the network, followed by subsequent incorporation into the ClueGO for GO and KEGG signaling pathway enrichment analysis.

Results: In accordance with the topological importance, a total of 23 potential targets of KBL on vitiligo were identified as main hubs. Additionally, enrichment analysis suggested that targets of KBL on vitiligo were mainly clustered into multiple biological processes (associated with DNA translation, lymphocyte differentiation and activation, steroid biosynthesis, autoimmune and systemic inflammatory reaction, neuron apoptosis, and vitamin deficiency) and related pathways (TNF, JAK-STAT, ILs, TLRs, prolactin, and NF-B), indicating the underlying mechanisms of KBL on vitiligo.

Conclusion: In this work, we successfully illuminated the "multicompounds, multitargets" therapeutic action of KBL on vitiligo by using network pharmacology. Moreover, our present outcomes might shed light on the further clinical application of KBL on vitiligo treatment.

Citing Articles

ITRAQ Based Proteomics Reveals the Potential Mechanism of Placental Injury Induced by Prenatal Stress.

Li Y, Hou J, Yang L, Zhang T, Jiang Y, Du Z Int J Mol Sci. 2024; 25(18).

PMID: 39337469 PMC: 11432224. DOI: 10.3390/ijms25189978.


Mechanism of Action of a Chinese Herbal Compound Containing Quercetin, Luteolin, and Kaempferol in the Treatment of Vitiligo Based on Network Pharmacology and Experimental Verification.

Xu Z, Xie Y, Song J, Huang J, Shi W Evid Based Complement Alternat Med. 2022; 2022:7197533.

PMID: 36569347 PMC: 9788887. DOI: 10.1155/2022/7197533.


Revealing Potential Bioactive Compounds and Mechanisms of against COVID-19 via Network Pharmacology Study.

Oh K, Adnan M Curr Issues Mol Biol. 2022; 44(5):1788-1809.

PMID: 35678652 PMC: 9164027. DOI: 10.3390/cimb44050123.


Prenatal Stress Impairs Postnatal Learning and Memory Development via Disturbance of the cGMP-PKG Pathway and Oxidative Phosphorylation in the Hippocampus of Rats.

Li Y, Yang L, Hou J, Li X, Chen L, Zhu J Front Mol Neurosci. 2020; 13:158.

PMID: 33013315 PMC: 7509422. DOI: 10.3389/fnmol.2020.00158.


Deciphering the Molecular Targets and Mechanisms of HGWD in the Treatment of Rheumatoid Arthritis via Network Pharmacology and Molecular Docking.

Liu W, Fan Y, Tian C, Jin Y, Du S, Zeng P Evid Based Complement Alternat Med. 2020; 2020:7151634.

PMID: 32908565 PMC: 7471805. DOI: 10.1155/2020/7151634.

References
1.
Xiong Y, Yang Y, Xiong W, Yao Y, Wu H, Zhang M . Network pharmacology-based research on the active component and mechanism of the antihepatoma effect of Rubia cordifolia L. J Cell Biochem. 2019; 120(8):12461-12472. DOI: 10.1002/jcb.28513. View

2.
Xu X, Zhang W, Huang C, Li Y, Yu H, Wang Y . A novel chemometric method for the prediction of human oral bioavailability. Int J Mol Sci. 2012; 13(6):6964-6982. PMC: 3397506. DOI: 10.3390/ijms13066964. View

3.
Tang Y, Li M, Wang J, Pan Y, Wu F . CytoNCA: a cytoscape plugin for centrality analysis and evaluation of protein interaction networks. Biosystems. 2014; 127:67-72. DOI: 10.1016/j.biosystems.2014.11.005. View

4.
Rappaport N, Twik M, Plaschkes I, Nudel R, Iny Stein T, Levitt J . MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search. Nucleic Acids Res. 2016; 45(D1):D877-D887. PMC: 5210521. DOI: 10.1093/nar/gkw1012. View

5.
Kruger C, Schallreuter K . A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol. 2012; 51(10):1206-12. DOI: 10.1111/j.1365-4632.2011.05377.x. View